We are live on ! Find out more
BE

Bonness Enterprises Portfolio holdings

AUM $310M
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
-2.39%
1 Year Est. Return
+24.22%
3 Year Est. Return
+94.56%
5 Year Est. Return
+137.52%
10 Year Est. Return
+441.57%
AUM
$196M
AUM Growth
-$2.42M
Cap. Flow
+$3.16M
Cap. Flow %
1.61%
Top 10 Hldgs %
64.03%
Holding
40
New
–
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
PGR icon
Progressive
PGR
+$3.17M

Top Sells

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$6.4K
2
GE icon
GE Aerospace
GE
+$257

Sector Composition

Rank Sector Weight
1 Financials 31.4%
2 Healthcare 29.52%
3 Technology 24.48%
4 Industrials 4.16%
5 Consumer Staples 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGR icon
1
Progressive
PGR
$122B
$54.8M 27.92%
605,853
+33,245
+6% +$3.17M
SYK icon
2
Stryker
SYK
$131B
$18M 9.2%
68,400
– –
MSFT icon
3
Microsoft
MSFT
$3.62T
$13.1M 6.67%
46,400
– –
AAPL icon
4
Apple
AAPL
$4.45T
$7.77M 3.96%
54,940
– –
TMO icon
5
Thermo Fisher Scientific
TMO
$213B
$6.51M 3.32%
11,400
– –
JNJ icon
6
Johnson & Johnson
JNJ
$613B
$6.29M 3.21%
38,938
– –
MRK icon
7
Merck
MRK
$315B
$5.22M 2.66%
69,500
– –
INTC icon
8
Intel
INTC
$459B
$4.74M 2.42%
88,950
– –
NUE icon
9
Nucor
NUE
$59.5B
$4.66M 2.38%
47,350
– –
CSCO icon
10
Cisco
CSCO
$457B
$4.51M 2.3%
82,900
– –
UL icon
11
Unilever
UL
$137B
$4.12M 2.1%
67,591
– –
EMR icon
12
Emerson Electric
EMR
$86.7B
$4.1M 2.09%
43,500
– –
IBM icon
13
IBM
IBM
$213B
$4.09M 2.09%
30,819
– –
AMAT icon
14
Applied Materials
AMAT
$411B
$4.03M 2.05%
31,300
– –
ABBV icon
15
AbbVie
ABBV
$433B
$3.95M 2.01%
36,600
– –
MRSH
16
Marsh
MRSH
$92B
$3.91M 1.99%
25,800
– –
ABT icon
17
Abbott
ABT
$185B
$3.86M 1.97%
32,700
– –
PFE icon
18
Pfizer
PFE
$143B
$3.38M 1.72%
78,608
– –
BMY icon
19
Bristol-Myers Squibb
BMY
$134B
$3.14M 1.6%
53,100
– –
A icon
20
Agilent Technologies
A
$39.5B
$2.82M 1.44%
17,900
– –
UPS icon
21
United Parcel Service
UPS
$90.8B
$2.72M 1.39%
14,950
– –
WLY icon
22
John Wiley & Sons Class A
WLY
$2.7B
$2.53M 1.29%
48,400
– –
GSK icon
23
GSK
GSK
$103B
$2.45M 1.25%
51,360
– –
T icon
24
AT&T
T
$162B
$2.4M 1.22%
117,704
– –
PG icon
25
Procter & Gamble
PG
$338B
$2.29M 1.17%
16,400
– –
1
2

Similar funds

IPW
IronBridge Private Wealth Austin, Texas $310M AUM 41.13% 1-Year Est. Return
TL
Tradewinds LLC Raleigh, North Carolina $310M AUM 22.31% 1-Year Est. Return
RGC
Redwood Grove Capital Palo Alto, California $310M AUM 35.87% 1-Year Est. Return
IR
IAT Reinsurance New York $310M AUM 13.37% 1-Year Est. Return
TWM
TSA Wealth Management Houston, Texas $309M AUM 15.82% 1-Year Est. Return
PH
Pinnacle Holdings Tulsa, Oklahoma $309M AUM 18.8% 1-Year Est. Return
CCG
Cloverfields Capital Group Minneapolis, Minnesota $309M AUM 20.93% 1-Year Est. Return
FI
Financial Insights Tacoma, Washington $309M AUM 17.27% 1-Year Est. Return

Bonness Enterprises's Q3 2021 Portfolio in Review

As of Q3 2021, Bonness Enterprises held 40 positions worth $196M, down 1.2% from $199M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. Bonness Enterprises opened no new positions and made no exits, leaving the 40-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Technology.

  • Bonness Enterprises added most to Progressive in Q3 2021, an estimated $3.17M increase.
  • Bonness Enterprises's biggest Q3 2021 reduction was Organon & Co, cutting an estimated $6.4K.
  • Bonness Enterprises's ten largest holdings make up 64% of its $196M portfolio in Q3 2021.
  • Bonness Enterprises opened 0 new positions and closed 0 in Q3 2021.
  • Bonness Enterprises's portfolio value fell 1.2% quarter-over-quarter to $196M.

Based on Bonness Enterprises's 13F filing for Q3 2021, filed 12 Oct 2021.